DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN)

CUSIP: 253748206

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM NEW
Total 13F shares
1,178,924
Share change
+60,821
Total reported value
$1,394,000
Price per share
$1.18
Number of holders
12
Value change
+$41,780
Number of buys
7
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 253748206?
CUSIP 253748206 identifies DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN) as of Q4 2017

As of 31 Dec 2017, DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,178,924 shares. The largest 10 holders included Swift Run Capital Management, LLC, Vanguard Group Inc, WHITTIER TRUST CO OF NEVADA INC, Virtu Financial LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Signature Financial Management, Inc., UBS Group AG, IHT Wealth Management, LLC, and Advisor Group, Inc.. This page lists 12 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.